Drug Profile
MGN 1601
Alternative Names: MGN-1601Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Mologen
- Class Cancer vaccines; Cell therapies; Gene therapies; Tumour cell vaccines
- Mechanism of Action Cell replacements; Immunostimulants; Natural killer cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Suspended Renal cancer